Detalles de la búsqueda
1.
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.
Ann Oncol
; 35(3): 285-292, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061427
2.
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial.
Ann Oncol
; 32(6): 726-735, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794293
3.
[Is diabetes a risk factor of urinary tract infection in patients with ureteral obstruction? Results of a retrospective study]. / Le diabète est-il un facteur de risque d'infection urinaire dans les obstructions urétérales ? Résultats d'une étude rétrospective.
Rev Med Liege
; 75(3): 176-179, 2020 Mar.
Artículo
en Francés
| MEDLINE | ID: mdl-32157843
4.
[Evaluation of a supervised six-month exercise program in patients with prostate cancer receiving androgen-deprivation therapy]. / Evaluation du bénéfice d'un programme supervisé d'exercices chez des patients recevant une thérapie de déprivation androgénique pour un cancer prostatique.
Rev Med Liege
; 74(1): 36-40, 2019 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-30680972
5.
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Ann Oncol
; 29(11): 2200-2207, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30202945
6.
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Ann Oncol
; 27(2): 286-94, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26578735
7.
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
World J Urol
; 34(10): 1367-72, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26897499
8.
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 31(9): 1119-1134, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32593798
9.
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
Ann Oncol
; 26(4): 743-749, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515657
10.
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project.
Ann Oncol
; 26(12): 2392-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26371288
11.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Ann Oncol
; 26(8): 1589-604, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041764
12.
Long-Term Functional, Cosmetic and Sexual Outcomes of Hypospadias Correction Performed in Childhood.
Urol Int
; 95(2): 137-41, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26201846
13.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Ann Oncol
; 30(12): e3, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27141017
14.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: a systematic review]. / Troubles du bas appareil urinaire chez des patients atteints de la sclérose en plaques et kinésithérapie pelvi-périnéale : revue systématique.
Prog Urol
; 24(4): 222-8, 2014 Mar.
Artículo
en Francés
| MEDLINE | ID: mdl-24560290
15.
[Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: a randomized controlled trial]. / Kinésithérapie et symptômes du bas appareil urinaire chez des patients atteints de la sclérose en plaques : étude contrôlée randomisée.
Prog Urol
; 24(11): 697-707, 2014 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-25214451
16.
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial.
Ann Oncol
; 24(9): 2402-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23723295
17.
MRI for response assessment in metastatic bone disease.
Eur Radiol
; 23(7): 1986-97, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23455764
18.
Access to information and expectations of treatment decisions for prostate cancer patients--results of a European survey.
Eur J Cancer Care (Engl)
; 22(2): 210-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23320923
19.
[Intravesical active prostate bleeding diagnosed in B-mode ultrasound]. / Saignement actif prostatique intravésical diagnostiqué en échographie mode B.
Prog Urol
; 23(10): 906-8, 2013 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-24034804
20.
Non-metastatic CRPC and asymptomatic metastatic CRPC: which treatment for which patient?
Ann Oncol
; 23 Suppl 10: x251-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22987972